I
103D CONGRESS
1ST SESSION
H. R. 2813
To amend the Public Health Service Act to establish programs for the
prevention and control of Lyme disease.
IN THE HOUSE OF REPRESENTATIVES
JULY 30, 1993
Mr. HOCHBRUECKNER introduced the following bill; which was referred to the
Committee on Energy and Commerce
A BILL
To amend the Public Health Service Act to establish
programs for the prevention and control of Lyme disease.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘‘Lyme Disease Preven-
tion, Control, and Research Amendments of 1993’’.
SEC. 2. ESTABLISHMENT OF PROGRAMS FOR PREVENTION
AND CONTROL OF LYME DISEASE.
Title III of the Public Health Service Act (42 U.S.C.
241 et seq.), as amended by section 308 of Public Law
102–531 (106 Stat. 3495), is amended by inserting after
section 317D the following section:
‘‘PREVENTION AND CONTROL OF LYME DISEASE
‘‘SEC. 317E. (a) GENERAL PROGRAM.—
‘‘(1) PROGRAM
OF
GRANTS.—The Secretary,
acting through the Director of the Centers for Dis-
ease Control and Prevention, may make grants to
public and nonprofit private entities for the purpose
of carrying out programs for the prevention, control,
and treatment of Lyme disease.
‘‘(2) PREFERENCES
IN
MAKING
GRANTS.—In
making grants under paragraph (1), the Secretary
shall give preference to public and nonprofit private
entities that agree to carry out the purposes for
which the grant is made in 1 or more States for
which, as of calendar year 1990—
‘‘(A) a cumulative total of not less than
500 cases of Lyme disease was reported to and
confirmed by the Director of the Centers for
Disease Control and Prevention; or
‘‘(B) the cumulative per capita incidence of
cases of such disease (reported to and con-
firmed by such Director) was not less than 5
cases per 100,000 individuals.
‘‘(3) PRIORITIES
AMONG
AUTHORIZED
PUR-
POSES.—In making grants under paragraph (1), the
Secretary shall give priority to making grants for
the following:
‘‘(A) The development and evaluation of
strategies for the prevention and control of
Lyme disease (including, with respect to the
tick that carries the etiologic agent for the dis-
ease, strategies to manage deer and other
means through which the tick is introduced into
areas frequented by humans).
‘‘(B) Demonstration projects (administered
by State or local departments of health) to im-
prove methods of estimating the incidence and
prevalence of such disease, including projects
involving the reporting by physicians of cases of
the disease.
‘‘(C) Demonstration projects for the con-
trol of the disease in communities with a sub-
stantial incidence or prevalence of the disease.
‘‘(D) Studies to determine the effects of
the disease on the individual and on society, in-
cluding the economic costs of the disease.
‘‘(E) The improvement of diagnostic tests
for the disease.
‘‘(F) The provision of information and
education to health care professionals and the
public.
‘‘(G) Demonstration projects for treating
children for such disease.
‘‘(b) NATIONAL RESEARCH CENTERS FOR PREVEN-
TION, CONTROL, AND TREATMENT.—
‘‘(1) IN
GENERAL.—The Secretary, acting
through the Director of the Centers for Disease
Control and Prevention, may make awards of grants
or contracts to public and nonprofit private entities
for the establishment or operation (or both) of not
more than 5 centers to carry out basic and clinical
research on the prevention, control, and treatment of
Lyme disease.
‘‘(2) PREFERENCES IN MAKING AWARDS.—In
making awards under paragraph (1) for a center,
the Secretary shall give preference to an applicant
according to the extent to which the following ap-
plies to the applicant:
‘‘(A) The applicant is experienced in con-
ducting research on the prevention, control, and
treatment of Lyme disease.
‘‘(B) The center is or will be located in a
State described in subsection (a)(2).